{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:52:11Z","timestamp":1765889531815,"version":"3.43.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,10]]},"DOI":"10.7759\/cureus.89748","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T23:35:12Z","timestamp":1754868912000},"source":"Crossref","is-referenced-by-count":1,"title":["Serum Procalcitonin as an Indicator of Disease Severity and Clinical Deterioration in Hospitalized Patients With Acute Cholangitis"],"prefix":"10.7759","author":[{"given":"Landon A","family":"Kozai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torrey","family":"Czech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvin Jeremy N","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krixie","family":"Silangruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Fujii-Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.519","article-title":"Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis","volume":"25","author":"Mayumi T","year":"2018","unstructured":"Mayumi T, Okamoto K, Takada T, et al.. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018, 25:96-100. 10.1002\/jhbp.519","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2014.34.4.263","article-title":"Update on procalcitonin measurements","volume":"34","author":"Meisner M","year":"2014","unstructured":"Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014, 34:263-73. 10.3343\/alm.2014.34.4.263","journal-title":"Ann Lab Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(12)70323-7","article-title":"Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis","volume":"13","author":"Wacker C","year":"2013","unstructured":"Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013, 13:426-35. 10.1016\/s1473-3099(12)70323-7","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.05.002","article-title":"Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis","volume":"73","author":"Riedel S","year":"2012","unstructured":"Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis. 2012, 73:221-7. 10.1016\/j.diagmicrobio.2012.05.002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger RP","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al.. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013, 41:580-637. 10.1097\/CCM.0b013e31827e83af","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.2095-4352.2019.08.005","article-title":"Assessment values of procalcitonin, lactic acid, and disease severity scores in patients with sepsis [Article in Chinese]","volume":"31","author":"Wang J","year":"2019","unstructured":"Wang J, Wang H, Liu W, Zhang D, Guo S. Assessment values of procalcitonin, lactic acid, and disease severity scores in patients with sepsis [Article in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019, 31:938-41. 10.3760\/cma.j.issn.2095-4352.2019.08.005","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13049-019-0609-3","article-title":"Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with sepsis","volume":"27","author":"Liu Z","year":"2019","unstructured":"Liu Z, Meng Z, Li Y, Zhao J, Wu S, Gou S, Wu H. Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with sepsis. Scand J Trauma Resusc Emerg Med. 2019, 27:51. 10.1186\/s13049-019-0609-3","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2012.120520","article-title":"Usefulness of procalcitonin for severity assessment in patients with acute cholangitis","volume":"59","author":"Hamano K","year":"2013","unstructured":"Hamano K, Noguchi O, Matsumoto Y, et al.. Usefulness of procalcitonin for severity assessment in patients with acute cholangitis. Clin Lab. 2013, 59:177-83. 10.7754\/clin.lab.2012.120520","journal-title":"Clin Lab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2021.10.016","article-title":"The role of procalcitonin as a prognostic factor for acute cholangitis and infections in acute pancreatitis: a prospective cohort study from a European single center","volume":"24","author":"Alberti P","year":"2022","unstructured":"Alberti P, Pando E, Mata R, et al.. The role of procalcitonin as a prognostic factor for acute cholangitis and infections in acute pancreatitis: a prospective cohort study from a European single center. HPB (Oxford). 2022, 24:875-84. 10.1016\/j.hpb.2021.10.016","journal-title":"HPB (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1278-x","article-title":"Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study","volume":"52","author":"Umefune G","year":"2017","unstructured":"Umefune G, Kogure H, Hamada T, et al.. Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study. J Gastroenterol. 2017, 52:734-45. 10.1007\/s00535-016-1278-x","journal-title":"J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-018-4963-1","article-title":"Procalcitonin as a decision-supporting marker of urgent biliary decompression in acute cholangitis","volume":"63","author":"Lee YS","year":"2018","unstructured":"Lee YS, Cho KB, Park KS, Lee JY, Lee YJ. Procalcitonin as a decision-supporting marker of urgent biliary decompression in acute cholangitis. Dig Dis Sci. 2018, 63:2474-9. 10.1007\/s10620-018-4963-1","journal-title":"Dig Dis Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.512","article-title":"Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)","volume":"25","author":"Kiriyama S","year":"2018","unstructured":"Kiriyama S, Kozaka K, Takada T, et al.. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018, 25:17-30. 10.1002\/jhbp.512","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.132","article-title":"Procalcitonin as a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis","volume":"21","author":"Shinya S","year":"2014","unstructured":"Shinya S, Sasaki T, Yamashita Y, et al.. Procalcitonin as a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis. J Hepatobiliary Pancreat Sci. 2014, 21:777-85. 10.1002\/jhbp.132","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051155","article-title":"Procalcitonin to predict severity of acute cholangitis and need for urgent biliary decompression: systematic scoping review","volume":"11","author":"Silangcruz K","year":"2022","unstructured":"Silangcruz K, Nishimura Y, Czech T, Kimura N, Yess J. Procalcitonin to predict severity of acute cholangitis and need for urgent biliary decompression: systematic scoping review. J Clin Med. 2022, 11:1155. 10.3390\/jcm11051155","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-006-1152-y","article-title":"Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines","volume":"14","author":"Kimura Y","year":"2007","unstructured":"Kimura Y, Takada T, Kawarada Y, et al.. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007, 14:15-26. 10.1007\/s00534-006-1152-y","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01755-z","article-title":"Optimal timing of endoscopic retrograde cholangiopancreatography for acute cholangitis associated with distal malignant biliary obstruction","volume":"21","author":"Park N","year":"2021","unstructured":"Park N, Lee SH, You MS, et al.. Optimal timing of endoscopic retrograde cholangiopancreatography for acute cholangitis associated with distal malignant biliary obstruction. BMC Gastroenterol. 2021, 21:175. 10.1186\/s12876-021-01755-z","journal-title":"BMC Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2019.1704860","article-title":"Review of clinical practice guidelines on the use of procalcitonin in infections","volume":"52","author":"Tujula B","year":"2020","unstructured":"Tujula B, H\u00e4m\u00e4l\u00e4inen S, Kokki H, Pulkki K, Kokki M. Review of clinical practice guidelines on the use of procalcitonin in infections. Infect Dis (Lond). 2020, 52:227-34. 10.1080\/23744235.2019.1704860","journal-title":"Infect Dis (Lond)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27870","article-title":"The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: a systematic review and meta-analysis","volume":"120","author":"Tan M","year":"2019","unstructured":"Tan M, Lu Y, Jiang H, Zhang L. The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: a systematic review and meta-analysis. J Cell Biochem. 2019, 120:5852-9. 10.1002\/jcb.27870","journal-title":"J Cell Biochem"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010959.pub2","article-title":"Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock","volume":"1","author":"Andriolo BN","year":"2017","unstructured":"Andriolo BN, Andriolo RB, Salom\u00e3o R, Atallah \u00c1N. Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev. 2017, 1:CD010959. 10.1002\/14651858.CD010959.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0000000000000142","article-title":"Procalcitonin as a biomarker for infection-related mortality in cancer patients","volume":"9","author":"Sedef AM","year":"2015","unstructured":"Sedef AM, Kose F, Mertsoylu H, Ozyilkan O. Procalcitonin as a biomarker for infection-related mortality in cancer patients. Curr Opin Support Palliat Care. 2015, 9:168-73. 10.1097\/SPC.0000000000000142","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2010.214","article-title":"Circulating procalcitonin in aseptic carcinoma patients: a specificity study with (18)F-fluorodeoxyglucose positron-emission tomography\/computed tomography as benchmark","volume":"48","author":"Giovanella L","year":"2010","unstructured":"Giovanella L, Suriano S, Ricci R, Ravani P, Ceriani L. Circulating procalcitonin in aseptic carcinoma patients: a specificity study with (18)F-fluorodeoxyglucose positron-emission tomography\/computed tomography as benchmark. Clin Chem Lab Med. 2010, 48:1163-5. 10.1515\/CCLM.2010.214","journal-title":"Clin Chem Lab Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S95600","article-title":"Utility of blood procalcitonin concentration in the management of cancer patients with infections","volume":"9","author":"Durna\u015b B","year":"2016","unstructured":"Durna\u015b B, W\u0105tek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, G\u00f3\u017ad\u017a S. Utility of blood procalcitonin concentration in the management of cancer patients with infections. Onco Targets Ther. 2016, 9:469-75. 10.2147\/OTT.S95600","journal-title":"Onco Targets Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/378511-serum-procalcitonin-as-an-indicator-of-disease-severity-and-clinical-deterioration-in-hospitalized-patients-with-acute-cholangitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T23:35:13Z","timestamp":1754868913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/378511-serum-procalcitonin-as-an-indicator-of-disease-severity-and-clinical-deterioration-in-hospitalized-patients-with-acute-cholangitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.89748","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,10]]}}}